Pfizer vaccines for 5-11 year-olds may be coming soon

●

September 20, 2021

close up of a small vial of COVID vaccine with a red cap.

A vial of the Moderna COVID-19 vaccine. Photo by Momo Chang.

Pfizer/BioNTech, the maker of one of the COVID-19 vaccines, announced that their trial on children ages 5-11 is safe and that the vaccine generated antibodies to the virus. They are expected to submit to the US FDA for emergency use.

Over 2,000 children were given smaller doses (10 versus 30 micrograms) in the trial. Since school has resumed this year, there have been more cases of COVID-19 among children.

According to CNN, more than 28 million additional people will be eligible for the COVID-19 vaccine if the Pfizer vaccine for 5-11 year-olds is approved.

Author

Momo Chang

Momo Chang is a freelance journalist based in the San Francisco Bay Area and Senior Editor at Civil Eats. She served program alumni as the Oakland Voices Co-Director from 2019 to 2024. Her work focuses on healthcare, immigration, education, Asian American communities, food and culture. She is a former staff writer at the Oakland Tribune. Momo has received journalism awards from the Society of Professional Journalists for investigative reporting and the Asian American Journalists Association, among others. Her work has appeared in the East Bay Express, San Francisco Chronicle, Wired, and The New York Times. Momo is primarily a print journalist who also produces audio and visual stories for documentary film and radio. She is a Senior Contributing Editor for Hyphen and formerly the Content Manager at the Center for Asian American Media (CAAM).